Format

Send to

Choose Destination
Nat Rev Cancer. 2007 Sep;7(9):684-700.

Vitamin D signalling pathways in cancer: potential for anticancer therapeutics.

Author information

1
Department of Pharmacology, Roswell Park Cancer Institute, Buffalo, New York, USA.

Abstract

Epidemiological studies indicate that vitamin D insufficiency could have an aetiological role in various human cancers. Preclinical research indicates that the active metabolite of vitamin D, 1alpha,25(OH)2D3, also known as calcitriol, or vitamin D analogues might have potential as anticancer agents because their administration has antiproliferative effects, can activate apoptotic pathways and inhibit angiogenesis. In addition, 1alpha,25(OH)2D3 potentiates the anticancer effects of many cytotoxic and antiproliferative anticancer agents. Here, we outline the epidemiological, preclinical and clinical studies that support the development of 1alpha,25(OH)2D3 and vitamin D analogues as preventative and therapeutic anticancer agents.

PMID:
17721433
DOI:
10.1038/nrc2196
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center